Abbott misstates education credentials of Richard Gonzalez, Crain's reports Crain's says it has found that Abbott Labs (ABT) misstated the credentials of Richard Gonzalez, the executive tapped to become the CEO of AbbVie, its pharmaceutical spinoff, in at least nine regulatory filings between 2002-2007. The article says Gonzalez did not receive a bachelor's degree in biochemistry from the University of Houston or a master's degree in biochemistry from the University of Miami. Reference Link
News For ABT From The Last 14 Days
Check below for free stories on ABT the last two weeks.